Internal Medicine, Endocrinology, Diabetes, & Metabolism · Palestine, TX
NPI
1821007253
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2217 S Sycamore St
Palestine, TX, 75801
Phone (903) 729-3993
Groups this clinician bills Medicare through
Medicare paid, 2024
$436K
36,254 services
Medicare patients, 2024
629
Average age 73
Drug cost, 2024
$3.9M
11,635 prescriptions
Company payments, 2025
$357
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert G Pyle was code J0897 (injection, denosumab, 1 mg), 1,980 times for 27 patients. In total Robert G Pyle billed 36,254 services in 74 codes, and Medicare paid $436K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,980 | 27 | $20.11 | $40K |
| 36415 Venipuncture Blood Collection | Office | 1,123 | 550 | $8.63 | $9,697 |
| 85025 Blood Count | Office | 1,104 | 537 | $7.59 | $8,383 |
| 80053 Clinical Chemistry | Office | 1,096 | 537 | $10.33 | $11K |
| 84439 Clinical Chemistry | Office | 1,065 | 554 | $8.59 | $9,143 |
| 84481 Clinical Chemistry | Office | 1,037 | 545 | $16.11 | $17K |
| 83970 Clinical Chemistry | Office | 1,035 | 549 | $38.51 | $40K |
| 84443 Clinical Chemistry | Office | 1,033 | 536 | $16.46 | $17K |
| 82550 Clinical Chemistry | Office | 1,031 | 551 | $6.19 | $6,377 |
| 83735 Clinical Chemistry | Office | 1,018 | 525 | $6.36 | $6,477 |
| 80061 Clinical Chemistry | Office | 1,011 | 544 | $12.72 | $13K |
| 81001 Clinical Chemistry | Office | 982 | 509 | $3.01 | $2,955 |
| 82985 Clinical Chemistry | Office | 923 | 455 | $15.85 | $15K |
| 82607 Clinical Chemistry | Office | 918 | 527 | $14.36 | $13K |
| 84681 Clinical Chemistry | Office | 911 | 465 | $19.69 | $18K |
By year: 2022 $464K for 35,378 services; 2023 $442K for 36,922 services; 2024 $436K for 36,254 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,123 | 550 | $8.63 | $9,697 |
| 85025 Blood Count | 1,104 | 537 | $7.59 | $8,383 |
| 80053 Clinical Chemistry | 1,096 | 537 | $10.33 | $11K |
| 84439 Clinical Chemistry | 1,065 | 554 | $8.59 | $9,143 |
| 84481 Clinical Chemistry | 1,037 | 545 | $16.11 | $17K |
| 83970 Clinical Chemistry | 1,035 | 549 | $38.51 | $40K |
| 84443 Clinical Chemistry | 1,033 | 536 | $16.46 | $17K |
| 82550 Clinical Chemistry | 1,031 | 551 | $6.19 | $6,377 |
| 83735 Clinical Chemistry | 1,018 | 525 | $6.36 | $6,477 |
| 80061 Clinical Chemistry | 1,011 | 544 | $12.72 | $13K |
Medicare prescription drug claims, 2024
In 2024, the drug Robert G Pyle prescribed most often to Medicare patients was Glimepiride, with 1,072 prescriptions and refills. In total Robert G Pyle wrote 11,635 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Glimepiride Generic | 1,072 | 2,251 | 245 | $9,148 |
| Levothyroxine Sodium Generic | 947 | 2,001 | 220 | $7,646 |
| Ozempic Semaglutide | 924 | 1,146 | 159 | $1.1M |
| Metformin Hcl Er Metformin Hcl | 723 | 1,647 | 192 | $7,407 |
| Mounjaro Tirzepatide | 652 | 716 | 125 | $744K |
| Jardiance Empagliflozin | 590 | 852 | 105 | $484K |
| Metformin Hcl Generic | 535 | 1,108 | 122 | $4,632 |
| Pioglitazone Hcl Generic | 524 | 1,151 | 124 | $5,216 |
| Rosuvastatin Calcium Generic | 236 | 532 | 58 | $2,760 |
| Farxiga Dapagliflozin Propanediol | 229 | 334 | 43 | $184K |
| Trulicity Dulaglutide | 211 | 258 | 39 | $249K |
| Irbesartan Generic | 187 | 372 | 40 | $2,022 |
| Gabapentin Generic | 179 | 288 | 45 | $3,286 |
| Tresiba Flextouch U-100 Insulin Degludec | 177 | 374 | 64 | $139K |
| Humalog Kwikpen U-100 Insulin Lispro | 165 | 269 | 46 | $51K |
Brand drugs: 4,863 claims; generic drugs: 6,424 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert G Pyle $357 ($357 in general payments such as food, travel and fees) from 4 companies. The largest payer was Medtronic, Inc. with $103.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.